Veterinary Medicines

Vidalta 10 mg prolonged-release tablets for cats

Not authorised
  • Carbimazole
Download as PDF

Product identification

Medicine name:
Vidalta 10 mg prolonged-release tablets for cats
Vidalta vet. 10 mg depottabletter til katt
Active substance:
  • Carbimazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carbimazole
    10.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:
  • High density polyethylene container of 100 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
  • High density polyethylene container of 30 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 11-8535
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0442/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 26/01/2022
Download

Combined File of all Documents

English (PDF)
Published on: 20/10/2024
Download

ie-puar-mr-iev0442001-vidalta-10-mg-prolonged-release-tablets-for-cats-en.pdf

English (PDF)
Published on: 26/08/2024
Download